301 related articles for article (PubMed ID: 34075763)
1. The Role of Pathology in the Era of Personalized (Precision) Medicine: A Brief Review.
Vranic S; Gatalica Z
Acta Med Acad; 2021 Apr; 50(1):47-57. PubMed ID: 34075763
[TBL] [Abstract][Full Text] [Related]
2. Personalized cancer medicine and the future of pathology.
Moch H; Blank PR; Dietel M; Elmberger G; Kerr KM; Palacios J; Penault-Llorca F; Rossi G; Szucs TD
Virchows Arch; 2012 Jan; 460(1):3-8. PubMed ID: 22143935
[TBL] [Abstract][Full Text] [Related]
3. Precision diagnostics: integration of tissue pathology and genomics in cancer.
Sharma S; George P; Waddell N
Pathology; 2021 Dec; 53(7):809-817. PubMed ID: 34635323
[TBL] [Abstract][Full Text] [Related]
4. The changing role of pathologists from morphologists to molecular pathologists in the era of precision medicine.
Masood S
Breast J; 2020 Jan; 26(1):27-34. PubMed ID: 31876097
[TBL] [Abstract][Full Text] [Related]
5. [Molecular-Genetic Diagnosis and Molecular-Targeted Therapy in Cancer: Challenges in the Era of Precision Medicine].
Miyachi H
Rinsho Byori; 2015 Oct; 63(10):1188-93. PubMed ID: 26897855
[TBL] [Abstract][Full Text] [Related]
6. The leading role of pathology in assessing the somatic molecular alterations of cancer: Position Paper of the European Society of Pathology.
Matias-Guiu X; Stanta G; Carneiro F; Ryska A; Hoefler G; Moch H;
Virchows Arch; 2020 Apr; 476(4):491-497. PubMed ID: 32124002
[TBL] [Abstract][Full Text] [Related]
7. Integration of molecular pathology, epidemiology and social science for global precision medicine.
Nishi A; Milner DA; Giovannucci EL; Nishihara R; Tan AS; Kawachi I; Ogino S
Expert Rev Mol Diagn; 2016; 16(1):11-23. PubMed ID: 26636627
[TBL] [Abstract][Full Text] [Related]
8. Genetics, genomics, and cancer risk assessment: State of the Art and Future Directions in the Era of Personalized Medicine.
Weitzel JN; Blazer KR; MacDonald DJ; Culver JO; Offit K
CA Cancer J Clin; 2011; 61(5):327-59. PubMed ID: 21858794
[TBL] [Abstract][Full Text] [Related]
9. Personalized oncology: recent advances and future challenges.
Kalia M
Metabolism; 2013 Jan; 62 Suppl 1():S11-4. PubMed ID: 22999010
[TBL] [Abstract][Full Text] [Related]
10. Time for change: a new training programme for morpho-molecular pathologists?
Moore DA; Young CA; Morris HT; Oien KA; Lee JL; Jones JL; Salto-Tellez M
J Clin Pathol; 2018 Apr; 71(4):285-290. PubMed ID: 29113995
[TBL] [Abstract][Full Text] [Related]
11. Molecular pathology in the cancer clinic - where are we now and where are we headed?
Guillen A; Smallwood K; Killick DR
J Small Anim Pract; 2021 Jul; 62(7):507-520. PubMed ID: 33974272
[TBL] [Abstract][Full Text] [Related]
12. Enabling Precision Oncology Through Precision Diagnostics.
Brown NA; Elenitoba-Johnson KSJ
Annu Rev Pathol; 2020 Jan; 15():97-121. PubMed ID: 31977297
[TBL] [Abstract][Full Text] [Related]
13. Implementation of a Precision Pathology Program Focused on Oncology-Based Prognostic and Predictive Outcomes.
Donovan MJ; Cordon-Cardo C
Mol Diagn Ther; 2017 Apr; 21(2):115-123. PubMed ID: 28000172
[TBL] [Abstract][Full Text] [Related]
14. Perspective for the development of companion diagnostics and regulatory landscape to encourage personalized medicine in Japan.
Tazawa Y
Breast Cancer; 2016 Jan; 23(1):19-23. PubMed ID: 25605056
[TBL] [Abstract][Full Text] [Related]
15. Investigative pathology: leading the post-genomic revolution.
Berman DM; Bosenberg MW; Orwant RL; Thurberg BL; Draetta GF; Fletcher CD; Loda M
Lab Invest; 2012 Jan; 92(1):4-8. PubMed ID: 21986811
[TBL] [Abstract][Full Text] [Related]
16. Cancer genomics: from discovery science to personalized medicine.
Chin L; Andersen JN; Futreal PA
Nat Med; 2011 Mar; 17(3):297-303. PubMed ID: 21383744
[TBL] [Abstract][Full Text] [Related]
17. Molecular Diagnostics for Precision Medicine in Colorectal Cancer: Current Status and Future Perspective.
Chen G; Yang Z; Eshleman JR; Netto GJ; Lin MT
Biomed Res Int; 2016; 2016():9850690. PubMed ID: 27699178
[TBL] [Abstract][Full Text] [Related]
18. Molecular profiling for personalized cancer care.
Ashfaq R
Clin Exp Metastasis; 2012 Oct; 29(7):653-5. PubMed ID: 22678423
[TBL] [Abstract][Full Text] [Related]
19. Gene patents and personalized cancer care: impact of the Myriad case on clinical oncology.
Offit K; Bradbury A; Storm C; Merz JF; Noonan KE; Spence R
J Clin Oncol; 2013 Jul; 31(21):2743-8. PubMed ID: 23766521
[TBL] [Abstract][Full Text] [Related]
20. Practicing pathology in the era of big data and personalized medicine.
Gu J; Taylor CR
Appl Immunohistochem Mol Morphol; 2014 Jan; 22(1):1-9. PubMed ID: 24326463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
